Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Aurora Cannabis Completes Expansion of German Facility

Aurora Cannabis Completes Expansion of German Facility

MT newswireMT newswire2026/10/08 12:08

08:08 AM EDT, 10/08/2026 (MT Newswires) -- Aurora Cannabis (ACB) completed a major expansion of its facility in Leuna, Germany, which it said will more than double its expected annual flower output, the company said. The company said the expanded facility will to help it meet the demand for medical cannabis in Germany and other European markets, while improving supply chain resilience and operational efficiency. Aurora Cannabis also renamed the facility Aurora Horizon. Shares of the company were up 1.2% pre-bell.

08:08 AM EDT, 10/08/2026 (MT Newswires) -- Aurora Cannabis (ACB) completed a major expansion of its facility in Leuna, Germany, which it said will more than double its expected annual flower output, the company said. The company said the expanded facility will to help it meet the demand for medical cannabis in Germany and other European markets, while improving supply chain resilience and operational efficiency. Aurora Cannabis also renamed the facility Aurora Horizon. Shares of the company were up 1.2% pre-bell.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss